The European stock exchanges left the trade on Wednesday with small minuses. Investors took a step back after the recent strong boom.
The financial markets processed, among other things, the news that the British authorities have approved the use of the corona vaccine from pharmaceutical company AstraZeneca and the University of Oxford.
The British regulator MHRA has approved the vaccine that AstraZeneca has developed together with the University of Oxford for use in the United Kingdom. From January 4, the first Brits will be vaccinated with the new vaccine, which is cheaper and easier to store than the Pfizer vaccine.
In London, the pharmaceutical industry fell by almost 1 percent. AstraZeneca already won more than 3 percent the day before.
It has also been announced that the British House of Commons has approved the trade agreement that was concluded last week between the United Kingdom and the European Union. The trade deal also has yet to be approved by the British House of Lords. Then Queen Elizabeth will give her blessing to the deal.
The euro was worth $ 1.2283 compared to $ 1.2246 a day earlier. A barrel of US oil became 0.1 percent cheaper at $ 47.96. Brent oil climbed 0.2 percent in price to $ 51.17 a barrel.